In-Vitro Diagnostics Instruments Market Size to grow by USD 52.9 billion between 2024-2028
The In-Vitro Diagnostics Instruments Market is segmented by Product (Immunochemistry, Clinical microbiology, Molecular diagnostics, and Others), End-user (Hospitals and diagnostic laboratories, Academic and research institutes, and Home care), and Geography (North America, Europe, Asia, and Rest of World (ROW)). As per the Global Forecast research report 2024-2028 published by Technavio, the market size is estimated to grow by USD 52.9 billion, at a CAGR of 9.29% during the forecast period. There are several companies that are contributing to the market as per this report. Potential opportunities for physician office laboratories (POL) .
By Product, the Immunochemistry segment is projected to dominate the market size in 2024
The In-Vitro Diagnostics Instruments Market's automated segment, which dominates clinical laboratories with the highest test volume, is experiencing a decline in demand for immunochemistry analyzers in key markets like the US and Europe. Factors contributing to this trend include laboratory consolidation in France, late payments from Italy, Spain, and Portugal, and significant reductions in expenditure on blood glucose testing and clinical chemistry in the UK, France, and Germany, despite the rising number of Type II diabetic patients. These decreases have been partially offset by growth in other testing areas.
For insights on company offerings- Request a sample report!
By End-user, Hospitals and diagnostic laboratories segment is expected to hold the largest market size for the year 2024
In the healthcare industry, clinical reference laboratories play a pivotal role in disease diagnosis, treatment, and monitoring response to treatment. These laboratories, situated in hospitals and diagnostic centers, analyze clinical specimens to provide essential information for patient care. The data derived from these tests facilitates early diagnosis, enabling prompt intervention and reducing overall disease burden. Furthermore, the information obtained is instrumental in developing personalized medicines and disease surveillance programs, contributing significantly to clinical research and patient care. In-vitro diagnostic instruments are indispensable tools in these laboratories, ensuring accurate and efficient analysis of patient samples.
Why is North America forecasted to hold the largest regional market size in 2024?
The In-Vitro Diagnostics Instruments Market represents a significant growth opportunity for businesses, driven by the increasing demand for accurate and efficient diagnostic solutions. These instruments play a crucial role in detecting various diseases and conditions, enabling timely intervention and improved patient outcomes. Key trends shaping the market include automation, miniaturization, and the integration of artificial intelligence and machine learning technologies. Growth is expected to remain robust, underpinned by rising healthcare expenditures, an aging population, and a surge in chronic diseases.
To access the valuable insights - Download the Free Sample Report
Research Analysis Overview
The In-Vitro Diagnostics Instruments Market encompasses a wide range of medical devices used for the detection and diagnosis of various diseases and conditions. These instruments play a crucial role in identifying pathogens, including those causing tropical diseases such as Chikungunya, Malaria, and Zika, as well as non-communicable diseases like Alzheimer's, gastroenterology disorders, cardiology conditions, endocrine disorders, and chronic diseases such as stroke, heart disease, high blood cholesterol, and cancer. Molecular diagnostics, a significant segment of the in-vitro diagnostics market, facilitates the detection of genetic material from specimens, tissues, or bodily fluids, enabling early and accurate diagnosis of diseases. Laboratory technicians utilize these instruments to perform medical tests on samples, ensuring timely and precise results for patients. The in-vitro diagnostics market caters to various clinical laboratories and medical institutions, addressing the needs of various specialties, including cardiology, gastroenterology, and oncology. In addition, these instruments are essential in diagnosing age-associated diseases, such as Alzheimer's, and infectious diseases like Chikungunya, Malaria, Zika, and other tropical diseases. The market's growth is driven by the increasing prevalence of chronic conditions and the growing geriatric population.
Market Research Overview
According to Technavio, the In-Vitro Diagnostics Instruments Market is a significant segment of the global healthcare equipment industry. This market encompasses companies and products involved in the research, development, and manufacturing of advanced, differentiated, and clinically validated diagnostic instruments and devices. The global healthcare equipment market, which includes the revenue generated by manufacturers of various diagnostic equipment and devices, is a substantial sector within the healthcare industry. This market consists of the following segments: devices, which cover capital equipment, instruments, implants, accessories, and consumables utilized for disease diagnosis, monitoring, and treatment. Technavio calculates the market size based on the combined revenue of these diagnostic device manufacturers. - The In-Vitro Diagnostics Instruments Market is experiencing significant growth, fueled by the . Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
